STAND NUMBER: 5000

Exhibiting at the Oncology Convention

InnoMedica

InnoMedica is a Swiss nanomedicine company developing and commercializing a liposomal drug delivery platform. The clinical trial application of the first product Talidox is under review by the Swiss authorities after having shown strong preclinical evidence in cancer therapy. The second pipeline product Talineuren uses the liposomal platform to deliver a neuro-stimulant substance to the brain and shows regenerative effects against Parkinson in preclinical studies.

Visit Website

+41313110427